Search

everythinglearnresearchcommunity

for

Search:↓

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Erlotinib can cause hair loss and texture changes.

Surgeons' testosterone levels significantly increase during major head and neck cancer surgeries.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

A group has developed therapies that show promise for treating cancer and various other conditions.

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Anti-angiogenic drugs do not worsen COVID-19 severity in lung cancer patients.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Systematic symptom assessment helps prioritize care for children undergoing cancer treatment.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Self-care strategies, especially diet and lifestyle changes, help manage cancer treatment symptoms.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

A woman's small ovarian tumor causing high androgen levels was missed by several scans but found during surgery.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

The committee decided not to approve the drug due to low effectiveness and high risks.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.